8049 — Jilin Province Huinan Changlong Bio-pharmacy Co Income Statement
0.000.00%
Last trade - 00:00
- HK$761.94m
- HK$144.11m
- CNY841.55m
- 67
- 95
- 30
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 646 | 622 | 705 | 842 | 842 |
Cost of Revenue | |||||
Gross Profit | 538 | 531 | 580 | 648 | 584 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 470 | 471 | 528 | 644 | 643 |
Operating Profit | 175 | 151 | 178 | 198 | 199 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 175 | 150 | 177 | 197 | 198 |
Provision for Income Taxes | |||||
Net Income After Taxes | 145 | 127 | 143 | 194 | 148 |
Net Income Before Extraordinary Items | |||||
Net Income | 145 | 127 | 143 | 194 | 148 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 145 | 127 | 143 | 194 | 148 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.258 | 0.227 | 0.256 | 0.373 | 0.265 |
Dividends per Share | |||||
Special Dividends per Share |